174 related articles for article (PubMed ID: 27806853)
1. Cutaneous myeloid dendritic cell dyscrasia: A cutaneous clonal monocytosis associated with chronic myeloproliferative disorders and peripheral blood monocytosis.
Magro CM; Momtahen S; Verma S; Abraham RM; Friedman C; Nuovo GJ; Tam W
Ann Diagn Pathol; 2016 Dec; 25():85-91. PubMed ID: 27806853
[TBL] [Abstract][Full Text] [Related]
2. Histiocytoid Sweet's Syndrome: A localized cutaneous proliferation of macrophages frequently associated with chronic myeloproliferative disease.
Magro CM; Momtahen S; Nguyen GH; Wang X
Eur J Dermatol; 2015; 25(4):335-41. PubMed ID: 26067166
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous Manifestations of Myeloid Neoplasms Exhibit Broad and Divergent Morphologic and Immunophenotypic Features but Share Ancestral Clonal Mutations With Bone Marrow.
Sadigh S; DeAngelo DJ; Garcia JS; Hasserjian RP; Hergott CB; Lane AA; Lovitch SB; Lucas F; Luskin MR; Morgan EA; Pinkus GS; Pozdnyakova O; Rodig SJ; Shanmugam V; Tsai HK; Winer ES; Zemmour D; Kim AS
Mod Pathol; 2024 Jan; 37(1):100352. PubMed ID: 37839675
[TBL] [Abstract][Full Text] [Related]
4. CD1c(+) myeloid dendritic cells in myeloid neoplasia.
Meyerson HJ; Osei E; Schweitzer K; Blidaru G; Edinger A; Schlegelmilch J; Awadallah A; Goyal T
Cytometry B Clin Cytom; 2016 Jul; 90(4):337-48. PubMed ID: 26502918
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow leukaemic transformation of myelodysplastic syndrome revealed by a cutaneous Langerhans cell infiltrate: partial response to azacitidine.
Osio A; Elfatoiki F; Raffoux E; Vignon-Pennamen MD; de Labarthe A; Cordoliani F; Petrella T; Bagot M; Janin A; Battistella M; Bouaziz JD
Eur J Dermatol; 2013; 23(5):710-1. PubMed ID: 24125873
[No Abstract] [Full Text] [Related]
6. Chronic myelomonocytic leukemia masquerading as cutaneous indeterminate dendritic cell tumor: Expanding the spectrum of skin lesions in chronic myelomonocytic leukemia.
Loghavi S; Curry JL; Garcia-Manero G; Patel KP; Xu J; Khoury JD; Torres-Cabala CA; Nagarajan P; Aung PP; Gibson BR; Goodwin BP; Kelly BC; Korivi BR; Medeiros LJ; Prieto VG; Kantarjian HM; Bueso-Ramos CE; Tetzlaff MT
J Cutan Pathol; 2017 Dec; 44(12):1075-1079. PubMed ID: 28885734
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous extramedullary hemopoiesis in chronic myeloproliferative and myelodysplastic disorders.
Haniffa MA; Wilkins BS; Blasdale C; Simpson NB
J Am Acad Dermatol; 2006 Aug; 55(2 Suppl):S28-31. PubMed ID: 16843120
[TBL] [Abstract][Full Text] [Related]
8. Dendritic cells in bone marrow at diagnosis and after chemotherapy in adult patients with acute myeloid leukaemia.
Derolf AR; Laane E; Björklund E; Saft L; Björkholm M; Porwit A
Scand J Immunol; 2014 Dec; 80(6):424-31. PubMed ID: 25346147
[TBL] [Abstract][Full Text] [Related]
9. Nodal and extranodal tumor-forming accumulation of plasmacytoid monocytes/interferon-producing cells associated with myeloid disorders.
Vermi W; Facchetti F; Rosati S; Vergoni F; Rossi E; Festa S; Remotti D; Grigolato P; Massarelli G; Frizzera G
Am J Surg Pathol; 2004 May; 28(5):585-95. PubMed ID: 15105645
[TBL] [Abstract][Full Text] [Related]
10. Dermal Langerhans' cell tumor in chronic myelomonocytic leukemia.
Kaiserling E; Horny HP
Ultrastruct Pathol; 1988; 12(2):209-19. PubMed ID: 3163210
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical detection of p53, mdm2, waf1/p21, and Ki67 proteins in bone marrow biopsies in myelodysplastic syndroms, acute myelogenous leukaemias and chronic myeloproliferative disorders.
Kanavaros P; Stefanaki K; Rontogianni D; Darivianaki K; Vlychou M; Papadaki E; Eliopoulos G; Bakiri M; Matsouka C; Kakolyris S; Georgoulias V
Clin Exp Pathol; 1999; 47(5):231-8. PubMed ID: 10598372
[TBL] [Abstract][Full Text] [Related]
12. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
13. Plasmacytoid Dendritic Cell Dermatosis Associated to Myeloproliferative/Myelodysplastic Neoplasms.
Machan S; Alonso-Dominguez JM; Sánchez García FJ; Nieves Salgado R; Soto C; Castro Y; Pajares R; Manso R; Santonja C; Serrano Del Castillo C; Piris MA; Requena L; Rodríguez Pinilla SM
Am J Surg Pathol; 2022 Dec; 46(12):1623-1632. PubMed ID: 36001453
[TBL] [Abstract][Full Text] [Related]
14. Neutrophilic dermatoses and myeloproliferative disease: report of two cases.
Gibson LE; Dicken CH; Flach DB
Mayo Clin Proc; 1985 Nov; 60(11):735-40. PubMed ID: 3863998
[TBL] [Abstract][Full Text] [Related]
15. [Quantitative analysis of dendritic cell subsets in bone marrow of patients with acute myeloid leukemia].
Lin HR; Wang YZ; Wang DX; Chang Y; Hao L; Qin YZ; Li JL; Li LD; Huang XJ; Liu YR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1249-54. PubMed ID: 19840461
[TBL] [Abstract][Full Text] [Related]
16. Identification of lineage relationships and novel markers of blood and skin human dendritic cells.
Harman AN; Bye CR; Nasr N; Sandgren KJ; Kim M; Mercier SK; Botting RA; Lewin SR; Cunningham AL; Cameron PU
J Immunol; 2013 Jan; 190(1):66-79. PubMed ID: 23183897
[TBL] [Abstract][Full Text] [Related]
17. Clonality in the setting of Sweet's syndrome and pyoderma gangrenosum is not limited to underlying myeloproliferative disease.
Magro CM; Kiani B; Li J; Crowson AN
J Cutan Pathol; 2007 Jul; 34(7):526-34. PubMed ID: 17576331
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cell depletion in burn patients is regulated by MafB expression.
Williams KN; Szilagyi A; He LK; Conrad P; Halerz M; Gamelli RL; Shankar R; Muthumalaiappan K
J Burn Care Res; 2012; 33(6):747-58. PubMed ID: 22868453
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic value of bone marrow biopsy in chronic myeloproliferative disorders].
Bettini R; Marzetta K; Miglioranza A; Redaelli S; Maino C; Maffiolini A; Gorini M
Recenti Prog Med; 2003; 94(7-8):314-20. PubMed ID: 12868237
[TBL] [Abstract][Full Text] [Related]
20. The quality and quantity of leukemia-derived dendritic cells from patients with acute myeloid leukemia and myelodysplastic syndrome are a predictive factor for the lytic potential of dendritic cells-primed leukemia-specific T cells.
Grabrucker C; Liepert A; Dreyig J; Kremser A; Kroell T; Freudenreich M; Schmid C; Schweiger C; Tischer J; Kolb HJ; Schmetzer H
J Immunother; 2010 Jun; 33(5):523-37. PubMed ID: 20463595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
